The BFB cycle begins when the end region of a
chromosome, called its
telomere, breaks off.[4] When that chromosome subsequently replicates it forms two
sister chromatids which both lack a telomere.[4] Since telomeres appear at the end of chromatids, and function to prevent their ends from fusing with other chromatids, the lack of a telomere on these two sister chromatids causes them to fuse with one another. During
anaphase the sister chromatids will form a bridge where the
centromere in one of the sister chromatids will be pulled in one direction of the dividing cell, while the centromere of the other will be pulled in the opposite direction.[4] Being pulled in opposite directions will cause the two sister chromatids to break apart from each other, but not necessarily at the site that they fused.[4] This results in the two daughter cells receiving an uneven chromatid.[4] Since the two resulting chromatids lack telomeres, when they replicate the BFB cycle will repeat, and will continue every subsequent cell division until those chromatids receive a telomere, usually from a different chromatid through the process of
translocation.[4]
Implications in tumors
The presence of
chromosomal aberrations has been demonstrated in every type of malignant tumor.[5] Although BFB cycles are a major source of genome instability, the rearrangement signature predicted by this model is not commonly present in cancer genomes without other chromosome alterations like
chromothripsis. BFB cycles and chromothripsis might be mechanistically related. The chromosome bridge formation could trigger a mutational cascade through the accumulation of chromothripsis in each cell division. This mechanism could explain the evolution and subclonal heterogeneity of some human cancers.[6]
Detection
Breakage-fusion-bridge creates several identifiable cytogenetic abnormalities, such as anaphase bridges and dicentric chromosomes, which can be seen in progress using methods that have been available for decades.[2] More recent methods, such as
microarray hybridization and
sequencing technologies, allow to infer evidence of BFB after the process has ceased.[7][8][9][10][11][12] Two main types of such evidence are fold-back inversions and segment copy number patterns. Fold-back inversions are chimeric sequences that span head-to-head arrangements of inverted tandem-duplicated segments, and are expected to appear in BFB modified genomes. In addition, BFB induces amplification of segments of the original genome, where the number of repeats of each segment in the rearranged genome can be
experimentally measured. Whilst the number of possible copy number patterns (each pattern a segmentation of the original genome and corresponding segment counts) is large,[13] testing whether a given copy number pattern was produced by BFB can be efficiently decided computationally.[14] While other genome instability mechanisms may also induce fold-back inversions and relatively short BFB-like copy number patterns,[15] it is unlikely that such mechanisms will induce sufficiently long copy number patterns coupled with significant presence of fold-back inversions, and therefore when such evidence are observed they are considered to be indicative of BFB.[14]
^Shuster, Michele I.; Han, Limin; Le Beau, Michelle M.; Davis, Elizabeth; Sawicki, Mark; Lese, Christa M.; Park, No-Hee; Colicelli, John; Gollin, Susanne M. (2000). "A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification". Genes, Chromosomes and Cancer. 28 (2): 153–63.
doi:
10.1002/(SICI)1098-2264(200006)28:2<153::AID-GCC4>3.0.CO;2-9.
PMID10825000.
S2CID8311135.
^Lim, Gloria; Karaskova, Jana; Beheshti, Ben; Vukovic, Bisera; Bayani, Jane; Selvarajah, Shamini; Watson, Spencer K.; Lam, Wan L.; et al. (2005). "An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma". Genes, Chromosomes and Cancer. 42 (4): 392–403.
doi:
10.1002/gcc.20157.
PMID15660435.
S2CID35755871.
^Kitada, Kunio; Yamasaki, Tomoaki (2008). "The complicated copy number alterations in chromosome 7 of a lung cancer cell line is explained by a model based on repeated breakage-fusion-bridge cycles". Cancer Genetics and Cytogenetics. 185 (1): 11–9.
doi:
10.1016/j.cancergencyto.2008.04.005.
PMID18656688.
^Selvarajah, S.; Yoshimoto, M.; Ludkovski, O.; Park, P.C.; Bayani, J.; Thorner, P.; Maire, G.; Squire, J.A.; Zielenska, M. (2008). "Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH". Cytogenetic and Genome Research. 122 (1): 5–15.
doi:
10.1159/000151310.
PMID18931480.
S2CID28956141.